Kaj Blennow took his medical degree (MD) in 1984, and holds a Specialist Competence in both General Psychiatry and in Clinical Chemistry. He is Head of the Clinical Neurochemistry Lab at Sahlgrenska University Hospital, Gothenburg, Sweden, and Professor in Clinical Neurochemistry at the Sahlgrenska Academy, Mölndal campus at University of Gothenburg, Sweden. The Clinical Neurochemistry research group includes 16 post-docs and 6 PhD students.
The major research areas are cerebrospinal fluid biochemical markers, clinical proteomics, and the neurochemical pathogenesis of Alzheimer’s disease and other brain disorders.
Blennow has published more than 600 original research papers and 90 review articles in peer-reviewed journals, and has an H-index of 86 (Oct. 2014). He has received a number of scientific awards, such as The CINP Award (1992), the IPA Research Award (1993), the Alois Alzheimer Research Award (2001), the ECNP Clinical Research Award (2010), the Henry Wisniewski Lifetime Achievement Award in Alzheimer’s Disease Research (2011), and theThe International Foundation for Research in Alzheimer’s Disease (IFRAD) European Grand Prix in Research, Paris, 2013.
